CSLLY - U.S. to phase out funding for mRNA vaccine development
2025-08-06 07:05:31 ET
More on Moderna, Pfizer, etc.
- Pfizer Inc. (PFE) Q2 2025 Earnings Call Transcript
- Wall Street Lunch: Trump Threatens 250% Tariff On Pharma
- Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle
- Pfizer raises 2025 EPS guidance to $2.90–$3.10 while targeting margin expansion through $7.7B cost savings by 2027
- Pfizer CEO says pharma execs discussed Trump’s direct-to-consumer demand